CONCORD WEALTH PARTNERS – Alnylam Pharmaceuticals, Inc. Transaction History
CONCORD WEALTH PARTNERS portfolio value:
$0
portfolio value
CONCORD WEALTH PARTNERS quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -17 shares | -2K | $200.16 | 0 |
| Q2 2022 | share | Decrease | -86.72% | -111 shares | -19K | $145.85 | 17 |
| Q1 2022 | share | Increase | +7.56% | 9 shares | 1K | $163.29 | 128 |
| Q4 2021 | share | Increase | +46.91% | 38 shares | 5K | $171.03 | 119 |
| Q3 2021 | share | Increase | +62.00% | 31 shares | 7K | $188.81 | 81 |
| Q2 2021 | share | Increase | +13.64% | 6 shares | 2K | $169.52 | 50 |
| Q1 2021 | share | Increase | 0.00% | 44 shares | 6K | $141.19 | 44 |